LJL BIOSYSTEMS
LJL is developing and marketing proprietary technologies and products to accelerate and enhance the drug discovery process. LJL's proprietary integrated technology platform is comprised of instrumentation and fluorescence-based and other assay technologies designed to provide a flexible solution to the current and evolving HTS requirements of drug discovery laboratories. The drug discovery process involves several stages including target identification, compound synthesis, assay development, screening and lead optimization.
LJL BIOSYSTEMS
Industry:
Biotechnology Information Technology Product Design
Founded:
1988-01-01
Address:
Sunnyvale, California, United States
Country:
United States
Total Employee:
51+
Status:
Active
Total Funding:
0
Current Advisors List
Current Employees Featured
Stock Details
Investors List
Bay City Capital
Bay City Capital investment in Post-IPO Equity - LJL Biosystems
More informations about "LJL Biosystems"
LJL Biosystems - Crunchbase Company Profile & Funding
Alternatives and possible competitors to LJL Biosystems may include Proteovista and Healthetech. LJL is developing and marketing proprietary technologies and products to …See details»
LJL Biosystems Inc - Company Profile and News - Bloomberg …
LJL Biosystems, Inc. designs, produces, and sells products and services that accelerate and enhance the process of discovering new drugs. The Company's integrated technology …See details»
LJL BioSystems - PitchBook
Developer of technology for the drug-discovery and life sciences fields. The company develops and manufacturers automated instrumentation, reagents and microplates for clinical, research …See details»
LJL BioSystems To Merge With Molecular Devices In $263M Deal
Jun 9, 2000 · LJL BioSystems Inc. will merge with Molecular Devices Corp. in a stock deal valued at about $262.83 million. The companies are joining, they said, to create critical mass and …See details»
LJL Biosystems - Funding, Financials, Valuation & Investors
Mar 13, 1998 · LJL Biosystems is funded by Bay City Capital. LJL Biosystems has raised 1 round. This was a Post-IPO Equity round raised on Jan 1, 1999. Which funding types raised the most …See details»
LJL Biosystems - Ownership and Business Overview - Mergr
Aug 1, 2000 · LJL Biosystems, Inc. is a provider of automated instrumentation systems for clinical, research and drug development applications. What's Mergr? We built Mergr to save people …See details»
LJL Biosystems - Products, Competitors, Financials, Employees ...
LJL Biosystems, Inc. developed and manufactured automated instrumentation systems for clinical, research and drug development applications. The company was acquired by …See details»
LJL Biosystems, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore LJL Biosystems, Inc. with its drug pipeline, therapeutic area, technology platform, 6 literature.See details»
LJL Biosystems | Funding, Valuation & Investors | Finallot
Explore LJL Biosystems profile on Finallot for insights on its team, products, and industry - LJL is developing and marketing proprietary technologies and products to accelerate and enhance …See details»
LJL Biosystems - Crunchbase
LJL is developing and marketing proprietary technologies and products to accelerate and enhance the drug discovery process.See details»
LJL BioSystems, Inc. (Acquired By Molecular Devices Corporation)
Find out more about LJL BioSystems, Inc. (Acquired By Molecular Devices Corporation) including the VentureRadar Innovation and Growth scores, Similar Companies and more.See details»
LJL BioSystems Company Profile | Management and Employees …
LJL BioSystems designs, produces and sells infrastructure tools that accelerate and enhance the process of discovering new drugs in the genomics and post-genomics era.See details»
Leytes, Lev J. - The Wall Street Transcript
LEV J. LEYTES is the principal founder, Chairman of the Board of Directors and CEO of LJL BioSystems, Inc., a life science technology company, focused on supplying advanced …See details»
LJL Biosystems acquired by Molecular Devices - Crunchbase
LJL Biosystems LJL is developing and marketing proprietary technologies and products to accelerate and enhance the drug discovery process. Acquiring Organization: Molecular DevicesSee details»
Galina Leytes - Stanford Distinguished Careers Institute
Prior to co-founding LJL BioSystems, Inc., Galina held senior technical and IT management positions at Charles Schwab, Stanford University, and a variety of tech companies. She …See details»
Lev Leytes - Stanford Distinguished Careers Institute
Lev Leytes is an entrepreneur, technologist, advisor to CEOs, investor and philanthropist. Together with his wife Galina Leytes, he was a co-founder, Chairman and CEO of LJL …See details»
LJL BioSystems receives $9.4 million in new financing: - HBW Insight
Jul 21, 1997 · LJL BioSystems a US developer of automated assay systems for use in clinical diagnostics, research and drug discovery has raised $9.4 million in a round of private financing.See details»
LJL Biosystems - Tech Stack, Apps, Patents & Trademarks
This year, LJL Biosystems is projected to spend $472.9K on IT, according to Aberdeen. UNLOCK PREMIUM DATA WITH DATABOOST . LJL is developing and marketing proprietary …See details»
LJL BioSystems, CRS Robotics Team to Accelerate Drug Discovery …
LJL BioSystems Inc. (Sunnyvale, CA) and CRS Robotics Corp. (Toronto) have installed a state-of-the-art lab automation system at Monsanto (St. Louis) that combines LJL's Analyst HT assay …See details»
LJL Biosystems - Contacts, Employees, Board Members
LJL is developing and marketing proprietary technologies and products to accelerate and enhance the drug discovery process.See details»